Candriam SCA’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $2.78M | Buy |
|
|||||
|
2023
Q3 | $1.62M | Sell |
|
|||||
|
2023
Q2 | $3.72M | Hold |
|
|||||
|
2023
Q1 | $3.13M | Hold |
|
|||||
|
2022
Q4 | $3.18M | Sell |
|
|||||
|
2022
Q3 | $7.91M | Hold |
|
|||||
|
2022
Q2 | $7.31M | Buy |
|
|||||
|
2022
Q1 | $7.35M | Hold |
|
|||||
|
2021
Q4 | $12M | Hold |
|
|||||
|
2021
Q3 | $13.6M | Hold |
|
|||||
|
2021
Q2 | $16.4M | Sell |
|
|||||
|
2021
Q1 | $9.56M | Hold |
|
|||||
|
2020
Q4 | $9.95M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $1.6M | Hold |
|
|||||
|
2019
Q2 | $1.96M | Hold |
|
|||||
|
2019
Q1 | $2.05M | Hold |
|
|||||
|
2018
Q4 | $1.64M | Hold |
|
|||||
|
2018
Q3 | $3.43M | Buy |
|
|||||
|
2018
Q2 | $2.73M | Buy |
|
|||||
|
2018
Q1 | $1.69M | Buy |
|
|||||
|
2017
Q4 | $1.25M | Buy |
|